Clonazepam
Back to searchMolecule Structure
Scientific Name
Clonazepam
Description of the Drug
Clonazepam is a long-acting benzodiazepine with intermediate onset commonly used to treat panic disorders, severe anxiety, and seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01068
http://www.drugbank.ca/drugs/DB01068
Brand Name(s)
Clonazepam, Klonopin, Klonopin rapidly disintegrating, Rivotril
Company Owner(s)
Mylan Pharmaceuticals Inc, Watson Laboratories Inc, Barr Laboratories Inc, Rubicon Research Private Ltd, Actavis Elizabeth Llc, Sandoz Inc, Sun Pharmaceutical Industries Inc, Hoffmann La Roche Inc, Par Pharmaceutical Inc, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL38899 | |
| PharmGKB | PA449050 | |
| Human Metabolome Database | HMDB0015201 | |
| WDI | CLONAZEPA | |
| DrugBank | DB01068 | |
| PubChem: Thomson Pharma | 14874486 | |
| PubChem | 2802 | |
| NMRShiftDB | 20237370 | |
| LINCS | LSM-45776 | |
| BindingDB | 50019213 | |
| EPA CompTox Dashboard | DTXSID1022845 | |
| DrugCentral | 703 | |
| Guide to Pharmacology | 6963 | |
| GSRS | 47042fc5-f0d2-4285-8e16-8bf517b95ded | |
| rxnorm | CLONAZEPAM | KLONOPIN |
| ChEBI | 3756 | |
| ZINC | ZINC000003813003 |
